[go: up one dir, main page]

PL2865663T3 - Nowa pochodna indanosulfamidu - Google Patents

Nowa pochodna indanosulfamidu

Info

Publication number
PL2865663T3
PL2865663T3 PL13807707T PL13807707T PL2865663T3 PL 2865663 T3 PL2865663 T3 PL 2865663T3 PL 13807707 T PL13807707 T PL 13807707T PL 13807707 T PL13807707 T PL 13807707T PL 2865663 T3 PL2865663 T3 PL 2865663T3
Authority
PL
Poland
Prior art keywords
novel
derivative
indanesulfamide derivative
novel indanesulfamide
indanesulfamide
Prior art date
Application number
PL13807707T
Other languages
English (en)
Inventor
Yuji Kazuta
Toru Watanabe
Keiichi Sorimachi
Minako Saito
Yoichi Kita
Toshiaki Tanaka
Hiroyuki Higashiyama
Takahisa Hanada
Tetsuyuki Teramoto
Takashi Kosasa
Yukio Ishikawa
Original Assignee
Eisai R&D Management Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co., Ltd. filed Critical Eisai R&D Management Co., Ltd.
Publication of PL2865663T3 publication Critical patent/PL2865663T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04Diamides of sulfuric acids
    • C07C307/08Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL13807707T 2012-06-21 2013-06-17 Nowa pochodna indanosulfamidu PL2865663T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261662626P 2012-06-21 2012-06-21
US201261709737P 2012-10-04 2012-10-04
US201361751331P 2013-01-11 2013-01-11

Publications (1)

Publication Number Publication Date
PL2865663T3 true PL2865663T3 (pl) 2017-09-29

Family

ID=49768740

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13807707T PL2865663T3 (pl) 2012-06-21 2013-06-17 Nowa pochodna indanosulfamidu

Country Status (35)

Country Link
US (1) US9018260B2 (pl)
EP (1) EP2865663B1 (pl)
JP (1) JP5883135B2 (pl)
KR (1) KR101951519B1 (pl)
CN (1) CN104395285B (pl)
AR (1) AR091506A1 (pl)
AU (1) AU2013278450B2 (pl)
BR (1) BR112014031565B1 (pl)
CA (1) CA2877097C (pl)
CL (1) CL2014003429A1 (pl)
CY (1) CY1119171T1 (pl)
DK (1) DK2865663T3 (pl)
ES (1) ES2628374T3 (pl)
HK (1) HK1207363A1 (pl)
HR (1) HRP20170863T1 (pl)
HU (1) HUE033583T2 (pl)
IL (1) IL236295A (pl)
JO (1) JO3263B1 (pl)
LT (1) LT2865663T (pl)
ME (1) ME02753B (pl)
MX (1) MX355261B (pl)
MY (1) MY169073A (pl)
NZ (1) NZ702974A (pl)
PE (1) PE20150284A1 (pl)
PH (1) PH12014502805B1 (pl)
PL (1) PL2865663T3 (pl)
PT (1) PT2865663T (pl)
RS (1) RS56073B1 (pl)
RU (1) RU2619937C2 (pl)
SG (1) SG11201408359PA (pl)
SI (1) SI2865663T1 (pl)
SM (1) SMT201700287T1 (pl)
TW (1) TWI597263B (pl)
WO (1) WO2013191144A1 (pl)
ZA (1) ZA201409248B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20201701T8 (hr) 2013-09-09 2022-01-07 Peloton Therapeutics, Inc. Aril eteri i njihove uporabe
US9884843B2 (en) 2013-12-16 2018-02-06 Peloton Therapeutics, Inc. Cyclic sulfone and sulfoximine analogs and uses thereof
KR102250214B1 (ko) * 2013-12-19 2021-05-07 에자이 알앤드디 매니지먼트 가부시키가이샤 1-인단설파미드 유도체를 포함하는 통증에 대한 치료제 및/또는 예방제
US10807948B2 (en) 2015-03-11 2020-10-20 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
WO2016145045A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Compositions for use in treating glioblastoma
EP3267792A4 (en) * 2015-03-11 2018-09-26 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
US10155726B2 (en) 2015-03-11 2018-12-18 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
WO2016168510A1 (en) 2015-04-17 2016-10-20 Peloton Therapeutics, Inc. Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
US9796697B2 (en) 2015-06-12 2017-10-24 Peloton Therapeutics, Inc. Tricyclic inhibitors of HIF-2-alpha and uses thereof
CN111801096B (zh) 2018-03-20 2024-03-05 卫材R&D管理有限公司 癫痫治疗剂
JP2024026905A (ja) * 2020-11-25 2024-02-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 てんかん治療剤
EP4480474A1 (en) 2022-04-27 2024-12-25 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treatment of parkinson's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3383414A (en) * 1964-08-26 1968-05-14 Sandoz Ag Benzocycloalkyl sulfamides
US3709677A (en) 1969-06-25 1973-01-09 Sandoz Ag N-substituted sulfamoyl compounds useful as herbicides
EP1401805A1 (en) * 2001-06-26 2004-03-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Valproyltaurinamide derivatives as anticonvulsant and cns active agents
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
EA010977B1 (ru) * 2004-08-24 2008-12-30 Янссен Фармацевтика Н.В. Бензоконденсированные гетероарилсульфамидные производные, полезные в качестве противоконвульсивных средств
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
CN100572365C (zh) * 2006-01-26 2009-12-23 全哲山 用作抗癫痫药的1,2,4-三唑并[4,3-a]喹啉-1-酮衍生物及其可药用盐
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
CL2007002994A1 (es) 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明(cyclopamine)類似物類
AR070949A1 (es) * 2007-10-19 2010-05-19 Solvay Pharm Gmbh Compuestos derivados de sulfamato de uso medico, medicamentos y composiciones farmaceuticas que los comprenden, procedimientos para preparar estos compuestos y su uso
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
AU2010233694A1 (en) * 2009-04-09 2011-09-29 Merck Sharp & Dohme B.V. Indane derivatives
CA2986521C (en) 2009-11-13 2020-06-30 Celgene International Ii Sarl Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
WO2011060391A1 (en) 2009-11-13 2011-05-19 Receptos, Inc. Selective heterocyclic sphingosine 1 phosphate receptor modulators
US20120302546A1 (en) * 2010-02-04 2012-11-29 Fox Chase Chemical Diversity Center, Inc. Novel sulfamides exhibiting neuroprotective action and methods for use thereof
US20120077814A1 (en) * 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives

Also Published As

Publication number Publication date
PT2865663T (pt) 2017-06-02
TW201402530A (zh) 2014-01-16
ZA201409248B (en) 2015-12-23
SG11201408359PA (en) 2015-01-29
BR112014031565B1 (pt) 2022-04-12
CA2877097A1 (en) 2013-12-27
US20140371319A1 (en) 2014-12-18
SI2865663T1 (sl) 2017-07-31
HRP20170863T1 (hr) 2017-09-08
CA2877097C (en) 2018-08-07
RU2014151013A (ru) 2016-08-10
MY169073A (en) 2019-02-13
JP5883135B2 (ja) 2016-03-09
JPWO2013191144A1 (ja) 2016-05-26
CN104395285A (zh) 2015-03-04
BR112014031565A2 (pt) 2017-06-27
DK2865663T3 (en) 2017-06-19
AU2013278450B2 (en) 2017-04-20
BR112014031565A8 (pt) 2021-06-08
PH12014502805A1 (en) 2015-02-23
KR101951519B1 (ko) 2019-02-22
MX2014015492A (es) 2015-05-08
US9018260B2 (en) 2015-04-28
IL236295A0 (en) 2015-02-26
PE20150284A1 (es) 2015-02-21
MX355261B (es) 2018-04-12
EP2865663B1 (en) 2017-04-05
ES2628374T3 (es) 2017-08-02
AU2013278450A1 (en) 2015-01-22
HK1207363A1 (en) 2016-01-29
LT2865663T (lt) 2017-07-10
KR20150032838A (ko) 2015-03-30
WO2013191144A1 (ja) 2013-12-27
JO3263B1 (ar) 2018-09-16
AR091506A1 (es) 2015-02-11
NZ702974A (en) 2016-03-31
EP2865663A1 (en) 2015-04-29
CY1119171T1 (el) 2018-02-14
TWI597263B (zh) 2017-09-01
ME02753B (me) 2018-01-20
EP2865663A4 (en) 2016-02-17
HUE033583T2 (hu) 2017-12-28
PH12014502805B1 (en) 2015-02-23
RS56073B1 (sr) 2017-10-31
SMT201700287T1 (it) 2017-07-18
IL236295A (en) 2016-09-29
CL2014003429A1 (es) 2015-03-27
CN104395285B (zh) 2016-04-13
RU2619937C2 (ru) 2017-05-22

Similar Documents

Publication Publication Date Title
HUS2200040I1 (hu) Benzimidazol-prolin származékok
HK1248702A1 (zh) 取代的吡咯烷-2-甲酰胺
EP2836211A4 (en) NOVEL PROCEDURE
HK1200830A1 (en) Substituted pyrrolidine-2-carboxamides -2-
HK1204797A1 (en) Novel anti-siglec15 antibody -siglec-15
HK1205740A1 (en) Pyrrolotriazinone derivatives
HK1207375A1 (en) Piperidinylpyrazolopyridine derivative
HK1207363A1 (en) Novel indanesulfamide derivative
HK1206724A1 (en) Substituted benzothienopyrimidines
AP2015008347A0 (en) Oxazolidin-2-one-pyrimidine derivatives
EP2934541A4 (en) NORIBOGAINE SUBSTITUTE
HK1206022A1 (zh) 取代的咪唑並噠嗪
HK1200824A1 (en) Substituted phenylazole derivative
PT2873660T (pt) Derivado de indolecarboxamida
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
HK1204621A1 (en) 4-alkanoylamino-3-pyrazolone derivative 4--3-
GB201207154D0 (en) Novel form